Want to join the conversation?
$AMGN presented new key data evaluating Kyprolis (carfilzomib) -based regimens in patients with relapsed multiple myeloma. The data showed Kyprolis in combination with dexamethasone extended disease progression compared to bortezomib plus dexamethasone across range of difficult-to-treat populations.
You are such a letdown $FII. I regret not selling you when you were nearing $33. Now I am stuck with you, you are stuck with me!
Can you imagine a food store with no cash registers? Well, it is coming true soon thanks to $AMZN. The company is opening its new grocery store in Seattle and it has no cash registers. AI takes over!